AEGR Aegerion Pharmaceuticals misses by $0.06, misses on revenue Aegerion Pharmaceuticals (NASDAQ:AEGR): Q3 EPS of -$0.20 misses by $0.06. Revenue of $43.67M (+167.4% Y/Y) misses by $4.97M. Shares -32.91%.